A Randomized Controlled Trial Investigating the Effects of Neurofeedback, Methylphenidate, and Physical Activity on Event-Related Potentials in Children with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 26, Issue 4, 2016, Pages 344-353

  Janssen, Tieme Willem Pieter ^a   Bink, Marleen ^a   Geladé, Katleen ^b   Van Mourik, Rosa ^c   Maras, Athanasios ^b   Oosterlaan, Jaap ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b Yulius Academy   (Netherlands)

^c ROYAL DUTCH KENTALIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; PLACEBO; CENTRAL STIMULANT AGENT;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN REGION; CHILD; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORRELATIONAL STUDY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; DSM-IV; ELECTROENCEPHALOGRAM; EVENT RELATED POTENTIAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROFEEDBACK; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; STRIATAL NUCLEUS; THALAMUS NUCLEUS; TREATMENT DURATION; TREATMENT RESPONSE; CLINICAL TRIAL; COMPARATIVE STUDY; ELECTROENCEPHALOGRAPHY; EVOKED RESPONSE; EXERCISE; KINESIOTHERAPY; PROCEDURES; TREATMENT OUTCOME;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; EXERCISE; EXERCISE THERAPY; FEMALE; HUMANS; MALE; METHYLPHENIDATE; NEUROFEEDBACK; TREATMENT OUTCOME;

EID: 84969916089     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2015.0144     Document Type: Article

References (55)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association; 1994.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision. (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000.
3. Arnold LE, Lofthouse N, Hersch S, Pan X, Hurt E, Bates B, Kassouf K, Moone S, Grantier C: EEG neurofeedback for ADHD: Doubleblind sham-controlled randomized pilot feasibility trial. J Atten Disord 17:410-419, 2013.
4. Arns M, Heinrich H, Strehl U: Evaluation of neurofeedback in ADHD: The long and winding road. Biol Psychol 95:108-15, 2014.
5. Arns M, Ridder S De, Strehl U: Efficacy of neurofeedback treatment in ADHD: The Effects on Inattention, Impulsivity and Hyperactivity. A Meta-Analysis. Clin EEG Neurosci 40:180-189, 2009.
6. Barkley RA: Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychol Bull 121:65-94, 1997.
7. Biederman J: Attention-deficit/hyperactivity disorder: A selective overview. Biol Psychiatry 57:1215-1220, 2005.
8. Coghill D, Seth S, Pedroso S, Usala T, Currie J, Gagliano A: Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit/hyperactivity disorder: Evidence from a systematic review and a meta-analysis. Biol Psychiatry 76:603-615, 2013.
9. Coghill D, Soutullo C, d'Aubuisson C, Preuss U, Lindback T, Silverberg M, Buitelaar J: Impact of attention-deficit/hyperactivity disorder on the patient and family: Results from a European survey. Child Adolesc Psychiatry Ment Health 2:31, 2008.
10. Cohen J, Cohen P, West S, Aiken L: Applied multiple regression and correlation analysis for the behavioral sciences. (3rd Ed). New York: Routledge, 2013.
11. Dallal GE: Randomization plan generator; first generator, 2007. Available at http://www.randomization.com. Accessed February 2010.
12. Duric NS, Assmus J, Gundersen D, Elgen IB: Neurofeedback for the treatment of children and adolescents with ADHD: A randomized and controlled clinical trial using parental reports. BMC Psychiatry 12:107, 2012.
13. Enriquez-Geppert S, Konrad C, Pantev C, Huster RJ: Conflict and inhibition differentially affect the N200/P300 complex in a combined go/nogo and stop-signal task. Neuroimage 51:877-887, 2010.
14. Faraone SV, Buitelaar J: Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. Eur Child Adolesc Psychiatry 19:353-364, 2010.
15. Faul F, Erdefelder E, Lang AG, Bunchner A: G∗power 3: A flexible statistical power analysis program for the social, behavioral and biomedical sciences. Behav Res Methods 39:175-191, 2007.
16. Fonov V, Evans A, McKinstry R, Almli C, Collins D: Unbiased nonlinear average age-appropriate brain templates from birth to adulthood. Neuroimage 47:S102, 2009.
17. Fonov V, Evans AC, Botteron K, Almli CR, McKinstry RC, Collins DL: Unbiased average age-appropriate atlases for pediatric studies. Neuroimage 54:313-327, 2011.
18. Gevensleben H, Rothenberger A, Moll GH, Heinrich H: Neurofeedback in children with ADHD: validation and challenges. Expert Rev Neurother 12:447-460, 2012.
19. Graham J, Coghill D: Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management. CNS Drugs 22:213-237, 2008.
20. Grave de Peralta Menendez R, Gonzalez Andino S, Lantz G, Michel CM, Landis T: Noninvasive localization of electromagnetic epileptic activity. I. Method descriptions and simulations. Brain Topogr 14:131-137, 2001.
21. Grave de Peralta Menendez R, Murray MM, Michel CM, Martuzzi R, Gonzalez Andino SL: Electrical neuroimaging based on biophysical constraints. Neuroimage 21:527-539, 2004.
22. Greenhill LL, Abikoff HB, Arnold LE, Cantwell DP, Conners K, Elliott G, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, March JS, Newcorn J, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wells K: Medication treatment strategies in the MTA study: Relevance to clinicians and researchers. J Am Acadamy Child Adolesc Psychiatry 34:1304-1313, 1996.
23. Greenhill LL, Halperin JM, Abikoff H: Stimulant medications. J Am Acadamy Child Adolesc Psychiatry 38:503-512, 1999.
24. Groom MJ, Scerif G, Liddle PF, Batty MJ, Liddle EB, Roberts KL, Cahill JD, Liotti M, Hollis C: Effects of motivation and medication on electrophysiological markers of response inhibition in children with attention-deficit/hyperactivity disorder. Biol Psychiatry 67: 624-631, 2010.
25. Halperin JM, Berwid OG, O'Neill S: Healthy body, healthy mind? The effectiveness of physical activity to treat ADHD in children. Child Adolesc Psychiatr Clin N Am 23:899-936, 2014.
26. Hart H, Radua J, Nakao T, Mataix-Cols D, Rubia K: Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: Exploring taskspecific, stimulant medication, and age effects. JAMA Psychiatry 70:185-198, 2013.
27. IBM Corporation: IBM SPSS Statistics for Windows; 2011.
28. Janssen TWP, Heslenfeld DJ, van Mourik R, Gelade K, Maras A, Oosterlaan J: Alterations in the ventral attention network during the stop-signal task in children with ADHD: An event-related potential source imaging study. J Atten Disord, 2015 [Epub ahead of print].
29. Johnstone S, Barry R, Clarke AR: Ten years on: A follow-up review of ERP research in attention-deficit/hyperactivity disorder. Clin Neurophysiol 124:644-657, 2013.
30. Kropotov JD, Grin-Yatsenko VA, Ponomarev VA, Chutko LS, Yakovenko EA, Nikishena IS: Changes in EEG spectrograms, eventrelated potentials and event-related desynchronization induced by relative beta training in ADHD children. J Neurother 11:3-11, 2007.
31. Laird AR, Fox PM, Price CJ, Glahn DC, Uecker AM, Lancaster JL, Turkeltaub PE, Kochunov P, Fox PT: ALE meta-analysis: controlling the false discovery rate and performing statistical contrasts. Hum Brain Mapp 25:155-164, 2005.
32. Lancaster JL, Tordesillas-Gutiérrez D, Martinez M, Salinas F, Evans A, Zilles K, Mazziotta JC, Fox PT: Bias between MNI and Talairach coordinates analyzed using the ICBM-152 brain template. Hum Brain Mapp 28:1194-1205, 2007.
33. Loo SK, Makeig S: Clinical utility of EEG in attention-deficit/hyperactivity disorder: A research update. Neurotherapeutics 9:569-587, 2012.
34. Meisel V, Servera M, Garcia-Banda G, Cardo E, Moreno I: Neurofeedback and standard pharmacological intervention in ADHD: A randomized controlled trial with six-month follow-up. Biol Psychol 94:12-21, 2013.
35. Michel CM, Murray MM, Lantz G, Gonzalez S, Spinelli L, Grave de Peralta Menendez R: EEG source imaging. Clin Neurophysiol 115:2195-2222, 2004.
36. MTA Cooperative Group: A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56:1073-1086, 1999.
37. Ogrim G, Hestad KA: Effects of neurofeedback versus stimulant medication in attention-deficit/hyperactivity disorder: A randomized pilot study. J Child Adolesc Psychopharmacol 23:448-457, 2013.
38. Paul-Jordanov I, Bechtold M, Gawrilow C: Methylphenidate and ifthen plans are comparable in modulating the P300 and increasing response inhibition in children with ADHD. Atten Defic Hyperact Disord 2:115-126, 2010.
39. Pelham WE, Gnagy EM, Greensalade KE, Milich R: Teacher ratings of DSM-III-R symptoms for the disruptive behavior disorders. J Am Acadamy Child Adolesc Psychiatry 31:210-218, 1992.
40. Perrin F, Pernier J, Bertrand O, Echallier JF: Spherical splines for scalp potential and current density mapping. Electroencephalogr Clin Neurophysiol 72:184-187, 1989.
41. Pliszka SR, Liotti M, Bailey BY, Perez R, Glahn D, Semrud-Clikeman M: Electrophysiological effects of stimulant treatment on inhibitory control in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 17:356-66, 2007.
42. Ramautar JR, Kok A, Ridderinkhof KR: Effects of stop-signal probability in the stop-signal paradigm: The N2/P3 complex further validated. Brain Cogn 56:234-252, 2004.
43. Rommel A-S, Halperin JM, Mill J, Asherson P, Kuntsi J: Protection from genetic diathesis in attention-deficit/hyperactivity disorder: possible complementary roles of exercise. J Am Acad Child Adolesc Psychiatry 52:900-910, 2013.
44. Rosa-Neto P, Lou HC, Cumming P, Pryds O, Karrebaek H, Lunding J, Gjedde A: Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder. Neuroimage 25:868-876, 2005.
45. Schlegelmilch F, Markert S, Berkes S, Schellhorn K: Online ocular artifact removal for dc-EEG-signals: Estimation of dc-level. Biomed Tech 2:340-341, 2004.
46. Seifert J, Scheuerpflug P, Zillessen K-E, Fallgatter A, Warnke A: Electrophysiological investigation of the effectiveness of methylphenidate in children with and without ADHD. J Neural Transm 110:821-829, 2003.
47. Snyder SM, Hall JR: A meta-analysis of quantitative EEG power associated with attention-deficit hyperactivity disorder. J Clin Neurophysiol 23:440-455, 2006.
48. Sonuga-Barke EJS, Brandeis D, Cortese S,Daley D, Ferrin M, Holtmann M, Stevenson J, DanckaertsM, van der Oord S, DöpfnerM, Dittmann RW, Simonoff E, Zuddas A, Banaschewski T, Buitelaar J, Coghill D, Hollis C, Konofal E, Lecendreux M, Wong ICK, Sergeant J: Nonpharmacological interventions for ADHD: Systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry 170:275-89, 2013.
49. Van Boxtel GJ, van der Molen MW, Jennings JR, Brunia CH: A psychophysiological analysis of inhibitory motor control in the stopsignal paradigm. Biol Psychol 58:229-262, 2001.
50. Van Dongen-Boomsma M, Vollebregt MA, Slaats-Willemse D, Buitelaar JK: A randomized placebo-controlled trial of electroencephalographic (EEG) neurofeedback in children with attentiondeficit/hyperactivity disorder. J Clin Psychiatry 74:821-827, 2013.
51. Vasey MW, Thayer JF: The continuing problem of false positives in repeated measures ANOVA in psychophysiology: A multivariate solution. Psychophysiology 24:479-486, 1987.
52. Volkow N, Wang G, Kollins S, Wigal T, Newcorn J, Telang F, Fowler J, Zhu W, Logan J, Ma Y, Pradhan K, Wong C, Swanson JM: Evaluating dopamine reward pathway clinical implications. JAMA 302:1084-1091, 2009.
53. Wangler S, Gevensleben H, Albrecht B, Studer P, Rothenberger A, Moll GH, Heinrich H: Neurofeedback in children with ADHD: Specific event-related potential findings of a randomized controlled trial. Clin Neurophysiol 122:942-950, 2011.
54. Willcutt EG: The prevalence of DSM-IV attention-deficit/hyperactivity disorder: A meta-analytic review. Neurotherapeutics 9:490-499, 2012.
55. Woldorff MG: Distortion of ERP averages due to overlap from temporally adjacent ERPs: analysis and correction. Psychophysiology 30:98-119, 1993.